As of June 18, 2025, Rion Co Ltd (6823.T) reports a ROE (Return on Equity) of 9.10%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Rion Co Ltd's ROE (Return on Equity)
Over recent years, Rion Co Ltd's ROE (Return on Equity) has shown a moderate pattern. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2025-03-31 | 9.10% |
| 2024-03-31 | 9.08% |
| 2023-03-31 | 6.76% |
| 2022-03-31 | 8.82% |
| 2021-03-31 | 6.90% |
This slight downward trend highlights how Rion Co Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Rion Co Ltd's ROE (Return on Equity) to Peers
To better understand Rion Co Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Rion Co Ltd (6823.T) | 9.10% |
| Lutronic Corp (085370.KQ) | 28.13% |
| Mizuho Medy Co Ltd (4595.T) | 21.75% |
| Olympus Corp (7733.T) | 15.68% |
| Japan Lifeline Co Ltd (7575.T) | 15.55% |
| Daiken Medical Co Ltd (7775.T) | 14.60% |
Compared to its competitors, Rion Co Ltd's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.